Neuraminidase treatment abrogates the binding abnormality of IgA1 from IgA nephropathy patients and the differential charge distribution of its alpha-heavy chains

We have studied the interaction of the Gal-GalNAc-reactive champedak lectin-C with neuraminidase-treated and untreated IgA1 from IgA nephropathy patients. The binding ability of the lectin to untreated IgA1 from IgA nephropathy patients was significantly lower as compared to the untreated IgA1 from...

Full description

Saved in:
Bibliographic Details
Main Authors: Hashim, O.H., Shuib, A.S., Chua, C.T.
Format: Article
Published: 2001
Subjects:
Online Access:http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstractBuch&ArtikelNr=46114&ProduktNr=227278
http://content.karger.com/ProdukteDB/produkte.asp?Aktion=ShowAbstractBuch&ArtikelNr=46114&ProduktNr=227278
http://eprints.um.edu.my/3444/1/Neuraminidase_treatment_abrogates_the_binding_abnormality_of_IgA1_from_IgA_nephropathy_patients.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!